FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885247445> ?p ?o ?g. }

• W2885247445 endingPage "508" @default.
• W2885247445 startingPage "499" @default.
• W2885247445 abstract "Background/aims Non-inferiority trials with time-to-event outcomes are becoming increasingly common. Designing non-inferiority trials is challenging, in particular, they require very large sample sizes. We hypothesized that the difference in restricted mean survival time, an alternative to the hazard ratio, could lead to smaller required sample sizes. Methods We show how to convert a margin for the hazard ratio into a margin for the difference in restricted mean survival time and how to calculate the required sample size under a Weibull survival distribution. We systematically selected non-inferiority trials published between 2013 and 2016 in seven major journals. Based on the protocol and article of each trial, we determined the clinically relevant time horizon of interest. We reconstructed individual patient data for the primary outcome and fit a Weibull distribution to the comparator arm. We converted the margin for the hazard ratio into the margin for the difference in restricted mean survival time. We tested for non-inferiority using the difference in restricted mean survival time and hazard ratio. We determined the required sample size based on both measures, using the type I error risk and power from the original trial design. Results We included 35 trials. We found evidence of non-proportional hazards in five (14%) trials. The hazard ratio and the difference in restricted mean survival time were consistent regarding non-inferiority testing, except in one trial where the difference in restricted mean survival time led to evidence of non-inferiority while the hazard ratio did not. The median hazard ratio margin was 1.43 (Q1–Q3, 1.29–1.75). The median of the corresponding margins for the difference in restricted mean survival time was −21 days (Q1–Q3, −36 to −8) for a median time horizon of 2.0 years (Q1–Q3, 1–3 years). The required sample size according to the difference in restricted mean survival time was smaller in 71% of trials, with a median relative decrease of 8.5% (Q1–Q3, 0.4%–38.0%). Across all 35 trials, about 25,000 participants would have been spared from enrollment using the difference in restricted mean survival time compared to hazard ratio for trial design. Conclusion The margins for the hazard ratio may seem large but translate to relatively small differences in restricted mean survival time. The difference in restricted mean survival time offers meaningful interpretation and can result in considerable reductions in sample size. Restricted mean survival time-based measures should be considered more widely in the design and analysis of non-inferiority trials with time-to-event outcomes." @default.
• W2885247445 created "2018-08-22" @default.
• W2885247445 creator A5014513186 @default.
• W2885247445 creator A5075829363 @default.
• W2885247445 date "2018-08-03" @default.
• W2885247445 modified "2023-09-26" @default.
• W2885247445 title "Design of non-inferiority randomized trials using the difference in restricted mean survival times" @default.
• W2885247445 cites W1594438765 @default.
• W2885247445 cites W1971051509 @default.
• W2885247445 cites W1971211622 @default.
• W2885247445 cites W1973885323 @default.
• W2885247445 cites W1982967337 @default.
• W2885247445 cites W1985352766 @default.
• W2885247445 cites W1987100300 @default.
• W2885247445 cites W1993595811 @default.
• W2885247445 cites W1997317197 @default.
• W2885247445 cites W1998077479 @default.
• W2885247445 cites W2004699731 @default.
• W2885247445 cites W2006019994 @default.
• W2885247445 cites W2011284201 @default.
• W2885247445 cites W2032541700 @default.
• W2885247445 cites W2041604784 @default.
• W2885247445 cites W2060584773 @default.
• W2885247445 cites W2068847846 @default.
• W2885247445 cites W2072013249 @default.
• W2885247445 cites W2077655204 @default.
• W2885247445 cites W2083085391 @default.
• W2885247445 cites W2092197509 @default.
• W2885247445 cites W2095687684 @default.
• W2885247445 cites W2124422742 @default.
• W2885247445 cites W2128842690 @default.
• W2885247445 cites W2144449199 @default.
• W2885247445 cites W2145774014 @default.
• W2885247445 cites W2146785136 @default.
• W2885247445 cites W2151981428 @default.
• W2885247445 cites W2152740900 @default.
• W2885247445 cites W2164963279 @default.
• W2885247445 cites W2168488550 @default.
• W2885247445 cites W2171811563 @default.
• W2885247445 cites W2218430322 @default.
• W2885247445 cites W2272869419 @default.
• W2885247445 cites W2275034928 @default.
• W2885247445 cites W2522328871 @default.
• W2885247445 cites W2529652362 @default.
• W2885247445 cites W2557435399 @default.
• W2885247445 cites W2590767873 @default.
• W2885247445 cites W2594307958 @default.
• W2885247445 cites W2622543996 @default.
• W2885247445 cites W2753244592 @default.
• W2885247445 cites W3139951753 @default.
• W2885247445 cites W3189355562 @default.
• W2885247445 cites W4244865769 @default.
• W2885247445 doi "https://doi.org/10.1177/1740774518792259" @default.
• W2885247445 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6133762" @default.
• W2885247445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30074407" @default.
• W2885247445 hasPublicationYear "2018" @default.
• W2885247445 type Work @default.
• W2885247445 sameAs 2885247445 @default.
• W2885247445 citedByCount "16" @default.
• W2885247445 countsByYear W28852474452019 @default.
• W2885247445 countsByYear W28852474452020 @default.
• W2885247445 countsByYear W28852474452021 @default.
• W2885247445 countsByYear W28852474452022 @default.
• W2885247445 countsByYear W28852474452023 @default.
• W2885247445 crossrefType "journal-article" @default.
• W2885247445 hasAuthorship W2885247445A5014513186 @default.
• W2885247445 hasAuthorship W2885247445A5075829363 @default.
• W2885247445 hasBestOaLocation W28852474452 @default.
• W2885247445 hasConcept C10515644 @default.
• W2885247445 hasConcept C105795698 @default.
• W2885247445 hasConcept C129848803 @default.
• W2885247445 hasConcept C173291955 @default.
• W2885247445 hasConcept C207103383 @default.
• W2885247445 hasConcept C33923547 @default.
• W2885247445 hasConcept C44249647 @default.
• W2885247445 hasConcept C50382708 @default.
• W2885247445 hasConcept C71924100 @default.
• W2885247445 hasConceptScore W2885247445C10515644 @default.
• W2885247445 hasConceptScore W2885247445C105795698 @default.
• W2885247445 hasConceptScore W2885247445C129848803 @default.
• W2885247445 hasConceptScore W2885247445C173291955 @default.
• W2885247445 hasConceptScore W2885247445C207103383 @default.
• W2885247445 hasConceptScore W2885247445C33923547 @default.
• W2885247445 hasConceptScore W2885247445C44249647 @default.
• W2885247445 hasConceptScore W2885247445C50382708 @default.
• W2885247445 hasConceptScore W2885247445C71924100 @default.
• W2885247445 hasFunder F4320337354 @default.
• W2885247445 hasIssue "5" @default.
• W2885247445 hasLocation W28852474451 @default.
• W2885247445 hasLocation W28852474452 @default.
• W2885247445 hasLocation W28852474453 @default.
• W2885247445 hasLocation W28852474454 @default.
• W2885247445 hasOpenAccess W2885247445 @default.
• W2885247445 hasPrimaryLocation W28852474451 @default.
• W2885247445 hasRelatedWork W2014671160 @default.
• W2885247445 hasRelatedWork W2072196024 @default.
• W2885247445 hasRelatedWork W2088206352 @default.
• W2885247445 hasRelatedWork W2130909087 @default.

• next